Santa Monica, Calif., June 1, 2011– Reprints Desk, Inc., a supplier of journal articles for research and evidence-based promotions, today announced the signing of a master referral agreement with Tokyo-based USACO Corporation. The agreement makes USACO the Japanese representative for Reprints Desk’s article supply system and services used by companies in Life Sciences and other intellectual property (IP)-based businesses. Terms of the deal were not released.
“Reprints Desk is honored to be able to serve Japanese customers with support from USACO Corporation, a respected service provider with more than 70 years history in providing quality scientific literature solutions in Japan in support of research, information management, and regulatory-compliant sales and marketing,” said Reprints Desk President and Chief Executive Officer Peter Derycz. “As the world’s second-largest pharmaceutical market and home for many of the world’s largest revenue-generating corporations, we believe that our entry into the Japanese market will be very successful for Japanese customers, Reprints Desk, and USACO.
USACO Corporation is a private information services company that links and networks societies and publishers with library and research customers through access to journals, books, database and documents in print and electronic formats. The company, founded as Yamakawa & Company in 1934, is led by President and Chief Executive Officer Mr. Shinichi Yamakawa.
“USACO looks forward to actively introducing Reprints Desk to current and future customers, and transforming the Japanese market by leading the shift from paper to digital document delivery service,” said USACO’s Yamakawa. “Japanese companies who transition to Reprints Desk will realize many benefits, including faster delivery in support of their critical research.”
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Reprints Desk earned the top ranking overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and scored a 97% customer satisfaction rating in Dun & Bradstreet’s 2009 Open Ratings survey of existing Reprints Desk customers.
For more information about Reprints Desk, visit www.reprintsdesk.com. For more information about USACO Corporation, visit www.usaco.co.jp.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.
USACO Corporation contributes to evolution of the scientific community in Japan. Since its origin as Yamakawa & Company in 1934, the company has worked closely with scientists and information specialists in universities, governments, research institutes and corporate research institutions. Customers trust USACO Corporation for help finding information, managing knowledge and developing new ideas.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company’s success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.